4//SEC Filing
Kroeger Christopher A. 4
Accession 0001658918-25-000008
CIK 0001770069other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:15 PM ET
Size
12.5 KB
Accession
0001658918-25-000008
Insider Transaction Report
Form 4
Kroeger Christopher A.
DirectorChief Executive Officer
Transactions
- Award
Voting Common Stock
2025-10-27+225,693→ 225,693 total - Award
Employee Stock Option (right to buy)
2025-10-27+916,164→ 916,164 totalExercise: $17.00Exp: 2035-10-26→ Voting Common Stock (916,164 underlying) - Conversion
Series C Preferred Stock
2025-10-28−65,477→ 0 total→ Voting Common Stock (3,895 underlying) - Conversion
Voting Common Stock
2025-10-28+3,895→ 229,588 total
Holdings
- 101,190(indirect: See footnote)
Voting Common Stock
Footnotes (5)
- [F1]Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- [F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- [F3]The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's IPO for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
- [F4]The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
- [F5]1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
MapLight Therapeutics, Inc.
CIK 0001770069
Entity typeother
Related Parties
1- filerCIK 0001658918
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:15 PM ET
- Size
- 12.5 KB